Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord. Its cause is unknown and it is uniformly fatal, typically within five years. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8, 9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O2.- to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-standing associations of some forms of ALS with mutations in genes coding for superoxide dismutase 1”
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Carlioz, A., & Touati, D. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04256.x · Cited by 784
Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J., Cann, H., Cohen, D., Lathrop, M., Lalouel, J.-M., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells.
Crapo, J. D., Oury, T., Rabouille, C., Slot, J. W., & Chang, L. Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10405 · Cited by 503
Richardson, J., Thomas, K. A., Rubin, B. H., & Richardson, D. C. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.4.1349 · Cited by 403
Familial adult motor neuron disease: amyotrophic lateralsclerosis
(1986) · Neurology · doi:10.1212/wnl.36.4.511 · Cited by 401
Self-citation
Research works printed but not linked: 7
- Kurland, L. T. Proc. Staff Meet Mayo Clin. 32, 449–462 (1957).
- Swerts, L. & Van Den Bergh, R. J. J. genet. Hum. 24, 247–255 (1976).
- Fridovich, I. Adv. Enzym. 58, 61–97 (1986).
- Ott, J. Am. hum. Genet. 28, 528–529 (1976).
- Ott, J. Analysis of Human Genetics 203–216 (Johns Hopkins Univ. Press, Baltimore, 1991).
- Hallewell, R. A. et al. in Superoxide Dismutase in Chemistry, Biology and Medicine (ed. Rotilio, G.) 249–256 (Elsevier, 1986).
- Muller, H. in Sixth internat. Congr. Genetics (ed. Jones, D.) 213–255 (Brooklyn Botanic Gardens, Menasha, 1932).
Cited by
Items 501–600 of 1,128
Strange, R. W., Antonyuk, S., Hough, M. A., Doucette, P. A., Rodriguez, J. A., Hart, P. J., Hayward, L. J., Valentine, J. S., & Hasnain, S. S. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00355-3 · Cited by 253
“Some 10% of ALS cases are familial (FALS), and dominant inheritance of point mutations in SOD1 has been implicated in about 20% of FALS cases.(10,11) Normal enzymatic activity is often undiminished by the mutations, yet these changes impart a presently unidentified toxic property to the protein.”
Antioxidants as treatment for neurodegenerative disorders
Moosmann, B., & Behl, C. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1407 · Cited by 252
Wu, D.-C., Ré, D. B., Nagai, M., Ischiropoulos, H., & Przedborski, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603670103 · Cited by 252
Sendtner, M., Carrol, P., Holtmann, B., Hughes, R. A., & Thoenen, H. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251110 · Cited by 253
Ezzi, S. A., Urushitani, M., & Julien, J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04531.x · Cited by 250
Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders
Carmeliet, P., & Storkebaum, E. (2002) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2001.0290 · Cited by 252
Preferential motor unit loss in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis
Hegedus, J., Putman, C. T., Tyreman, N., & Gordon, T. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.149286 · Cited by 248
“The transgenic male SOD1 mice were crossed with non-transgenic B6JSL hybrid females, and the resulting progeny were identified using a standard PCR protocol for the human SOD1 (Rosen, 1993).”
BackgroundMethodInfluentialTranscriptional responses to oxidative stress: Pathological and toxicological implications
Ma, Q. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.004 · Cited by 251
Vijayvergiya, C., Beal, M. F., Buck, J., & Manfredi, G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4385-04.2005 · Cited by 251
“Approximately 10% of ALS cases are familial (fALS), ϳ20% of which are associated with mutations in the Cu/Zn superoxide dismutase 1 gene SOD1 (Rosen et al., 1993).”
BackgroundFerrante, R. J., Shinobu, L. A., Schulz, J. B., Matthews, R. T., Thomas, C. E., Kowall, N. W., Gurney, M. E., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420309 · Cited by 250
Neurotrophic factor therapy for nervous system degenerative diseases
Hefti, F. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251109 · Cited by 251
Recruitment of the Mitochondrial-Dependent Apoptotic Pathway in Amyotrophic Lateral Sclerosis
Guégan, C., Vila, M., Rosoklija, G., Hays, A. P., & Przedborski, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06569.2001 · Cited by 250
Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase
Mitchell, J., Paul, P., Chen, H.-J., Morris, A., Payling, M., Falchi, M., Habgood, J., Panoutsou, S., Winkler, S., Tisato, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914128107 · Cited by 249
“In ALS spinal cord and in the G93A SOD1 mouse model of ALS, levels of D-serine and serine racemase (SR), which converts L-serine intoD-serine (22), aremarkedly elevated (23).”
BackgroundInfluentialA compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis
Schaefer, A. M., Sanes, J. R., & Lichtman, J. W. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20620 · Cited by 248
“During the past decade, several genes, including SOD1 (Rosen et al., 1993), have been identified that are mutated in heritable cases of ALS, which account for 5–10% of the total (Bruijn et al., 2004).”
BackgroundMolecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis
Corcia, P., Tauber, C., Vercoullie, J., Arlicot, N., Prunier, C., Praline, J., Nicolas, G., Venel, Y., Hommet, C., Baulieu, J.-L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052941 · Cited by 249
“The relationship between ALS and genetic factors is continuously being strengthened by such findings [3,4].”
BackgroundSmith, B. N., Topp, S. D., Fallini, C., Shibata, H., Chen, H.-J., Troakes, C., King, A., Ticozzi, N., Kenna, K. P., Soragia-Gkazi, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9157 · Cited by 247
Self-citationApoptosis in Human Disease: A New Skin for the Old Ceremony?
Fadeel, B., Orrenius, S., & Zhivotovsky, B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1888 · Cited by 249
Nguyen, M. D., D'Aigle, T., Gowing, G., Julien, J.-P., & Rivest, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4786-03.2004 · Cited by 248
“Missense mutations in the gene coding for the Cu–Zn SOD1, located on chromosome 21, account for 20% cases of familial ALS (Rosen et al., 1993; Cudkowicz et al., 1997).”
BackgroundJaarsma, D., Teuling, E., Haasdijk, E. D., De Zeeuw, C. I., & Hoogenraad, C. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5258-07.2008 · Cited by 247
“In a subset of patients, the disease is caused by mutations in the cytosolic CuZn superoxide dismutase (SOD1) gene (Rosen et al., 1993; Boillee et al., 2006a; Pasinelli and Brown, 2006).”
BackgroundDamiano, M., Starkov, A. A., Petri, S., Kipiani, K., Kiaei, M., Mattiazzi, M., Flint Beal, M., & Manfredi, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03619.x · Cited by 248
Fink, R. C., & Scandalios, J. G. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2739 · Cited by 245
An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis
Rotunno, M. S., & Bosco, D. A. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00253 · Cited by 245
Dubois-Dauphin, M., Frankowski, H., Tsujimoto, Y., Huarte, J., & Martinou, J. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3309 · Cited by 245
NEUROTROPHINS AND THEIR RECEPTORS IN NERVE INJURY AND REPAIR
EBADI, M., BASHIR, R. M., HEIDRICK, M. L., HAMADA, F. M., EL REFAEY, E., HAMED, A., HELAL, G., BAXI, M. D., CERUTIS, D. R., & LASSI, N. K. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00071-x · Cited by 246
The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Joshi, G., & A. Johnson, J. (2012) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912803252023 · Cited by 246
“Recently, triterpenoids that are potent activators of Nrf2-ARE pathway showed significant attenuation in weight loss, enhanced motor function and extended life span in hSOD1G93A mice when treated at presymptomatic age.”
BackgroundInfluentialThe microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins
Deora, V., Lee, J. D., Albornoz, E. A., McAlary, L., Jagaraj, C. J., Robertson, A. A. B., Atkin, J. D., Cooper, M. A., Schroder, K., Yerbury, J. J., et al. (2020) · Glia · doi:10.1002/glia.23728 · Cited by 245
“Notably, there is emerging evidence that SOD1WT forms aggregates and may play a role in sporadic and non-SOD1 familial ALS pathology (Forsberg et al., 2019; Pare et al., 2018; Rotunno & Bosco, 2013), so could represent a potential additional source of pathogenic ALS protein in humans.”
BackgroundOxygen and the control of gene expression
Pahl, H. L., & Baeuerle, P. A. (1994) · BioEssays · doi:10.1002/bies.950160709 · Cited by 245
The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches
Geloso, M. C., Corvino, V., Marchese, E., Serrano, A., Michetti, F., & D’Ambrosi, N. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00242 · Cited by 242
“…al., 2011), supposed to generate toxic RNA species, loss of protein and/or harmful dipeptide-repeats formation (Haeusler et al., 2016); superoxide dismutase 1 (SOD1; Rosen et al., 1993), forming toxic aggregates and interfering with mitochondrial functions and autophagy (Turner and Talbot, 2008).”
BackgroundSOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries
Rouleau, G. A., Clark, A. W., Rooke, K., Pramatarova, A., Krizus, A., Suchowersky, O., Julien, J., & Figlewicz, D. (1996) · Annals of Neurology · doi:10.1002/ana.410390119 · Cited by 245
Self-citationUrushitani, M., Ezzi, S. A., & Julien, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606201104 · Cited by 240
Impaired blood–brain/spinal cord barrier in ALS patients
Garbuzova-Davis, S., Hernandez-Ontiveros, D. G., Rodrigues, M. C. O., Haller, E., Frisina-Deyo, A., Mirtyl, S., Sallot, S., Saporta, S., Borlongan, C. V., & Sanberg, P. R. (2012) · Brain Research · doi:10.1016/j.brainres.2012.05.056 · Cited by 237
Late Onset Death of Motor Neurons in Mice Overexpressing Wild-Type Peripherin
Beaulieu, J.-M., Nguyen, M. D., & Julien, J.-P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.3.531 · Cited by 239
“Mutations in the copper/zinc superoxide dismutase (SOD1) gene have been found in z 20% of familial cases (2% of total ALS cases) (Rosen et al., 1993).”
BackgroundDisulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models
Jonsson, P. A., Graffmo, K. S., Andersen, P. M., Brännström, T., Lindberg, M., Oliveberg, M., & Marklund, S. L. (2006) · Brain · doi:10.1093/brain/awh704 · Cited by 239
“, 1995) and in some of these the disease has been linked to mutations in the CuZn-superoxide dismutase (SOD1) gene (Rosen et al., 1993).”
BackgroundA mutation in dynein rescues axonal transport defects and extends the life span of ALS mice
Kieran, D., Hafezparast, M., Bohnert, S., Dick, J. R. T., Martin, J., Schiavo, G., Fisher, E. M. C., & Greensmith, L. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501085 · Cited by 240
“suggested by the beneficial effects observed after peripheral axotomy (Kong and Xu, 1999) or impairment of p75NTR and neurotrophin-dependent signaling cascades ( Reichardt and Mobley, 2004 ).”
Mutations in PMR1 suppress oxidative damage in yeast cells lacking superoxide dismutase
Lapinskas, P. J., Cunningham, K. W., Liu, X. F., Fink, G. R., & Culotta, V. C. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1382 · Cited by 239
“Moreover, mutations in the humanSOD1gene encoding copper/zinc SOD have been correlated with amyotrophic lateral sclerosis, a fatal disorder affecting the motor neurons (22, 55 ).”
BackgroundMitochondrial dysfunction in ALS
Cozzolino, M., & Carrì, M. T. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.06.003 · Cited by 240
“Mutations in the SOD1 gene locus (ALS1) were the first discovered genetic cause for ALS (Rosen et al., 1993) and they are found in one fifth of fALS and in a few sALS as well.”
BackgroundHough, M. A., Grossmann, J. G., Antonyuk, S. V., Strange, R. W., Doucette, P. A., Rodriguez, J. A., Whitson, L. J., Hart, P. J., Hayward, L. J., Valentine, J. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305143101 · Cited by 239
CaMKII in the Cardiovascular System: Sensing Redox States
Erickson, J. R., He, B. J., Grumbach, I. M., & Anderson, M. E. (2011) · Physiological Reviews · doi:10.1152/physrev.00018.2010 · Cited by 237
“Indeed, even a single point mutation can be sufficient to drastically reduce the rate of catalysis for Cu,ZnSOD and result in severe pathophysiology, most notably amyotrophic lateral sclerosis (ALS) (194).”
Autophagy Induction as a Therapeutic Strategy for Neurodegenerative Diseases
Djajadikerta, A., Keshri, S., Pavel, M., Prestil, R., Ryan, L., & Rubinsztein, D. C. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.035 · Cited by 236
“[184] Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al.”
BackgroundSuperoxide dismutase, aging, and degenerative disease
Warner, H. R. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90080-9 · Cited by 238
Williamson, T. L., Bruijn, L. I., Zhu, Q., Anderson, K. L., Anderson, S. D., Julien, J.-P., & Cleveland, D. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9631 · Cited by 237
Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS
Heiman-Patterson, T. D., Deitch, J. S., Blankenhorn, E. P., Erwin, K. L., Perreault, M. J., Alexander, B. K., Byers, N., Toman, I., & Alexander, G. M. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.02.006 · Cited by 236
“the SOD1 gene that codes for the enzyme Cu/Zn superoxide dismutase [1,2].”
Backgroundvan Zundert, B., Peuscher, M. H., Hynynen, M., Chen, A., Neve, R. L., Brown, R. H., Constantine-Paton, M., & Bellingham, M. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1340-08.2008 · Cited by 236
“Approximately 25% of familial ALS (FALS) cases are caused by autosomal dominant mutations in the Cu-Zn superoxide dismutase 1 (SOD1) gene (Rosen et al., 1993).”
BackgroundSelf-citationPhase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
Kaufmann, P., Thompson, J. L. P., Levy, G., Buchsbaum, R., Shefner, J., Krivickas, L. S., Katz, J., Rollins, Y., Barohn, R. J., Jackson, C. E., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21743 · Cited by 235
“SOD 1 is an enzyme that plays a role in detoxifying free radicals.(7) In a transgenic mouse model of familial ALS, there is increased oxidative stress.”
BackgroundFamilial amyotrophic lateral sclerosis
Hand, C. K., & Rouleau, G. A. (2002) · Muscle & Nerve · doi:10.1002/mus.10001 · Cited by 235
“In summary, there is evidence for a number of possible toxic properties acquired by mutant SOD1.”
BackgroundInfluentialSelf-citationWang, J., Xu, G., Gonzales, V., Coonfield, M., Fromholt, D., Copeland, N. G., Jenkins, N. A., & Borchelt, D. R. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0498 · Cited by 235
Niyazov, D. M., Kahler, S. G., & Frye, R. E. (2016) · Molecular Syndromology · doi:10.1159/000446586 · Cited by 234
“Interestingly, deleterious SOD1 gene mutations, which have a dominant negative effect in the pathogenesis of amyotrophic lateral sclerosis, can also cause SMD [Rosen et al., 1993].”
BackgroundAmyotrophic lateral sclerosis: translating genetic discoveries into therapies
Akçimen, F., Lopez, E. R., Landers, J. E., Nath, A., Chiò, A., Chia, R., & Traynor, B. J. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00592-y · Cited by 234
Radical medicine: treating ageing to cure disease
Finkel, T. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1763 · Cited by 234
The Role of Sex and Sex Hormones in Neurodegenerative Diseases
Vegeto, E., Villa, A., Della Torre, S., Crippa, V., Rusmini, P., Cristofani, R., Galbiati, M., Maggi, A., & Poletti, A. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz005 · Cited by 232
SOD1, more than just an antioxidant
Eleutherio, E. C. A., Silva Magalhães, R. S., de Araújo Brasil, A., Monteiro Neto, J. R., & de Holanda Paranhos, L. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108701 · Cited by 232
Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis
Rakhit, R., & Chakrabartty, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.004 · Cited by 232
Transition metal homeostasis: from yeast to human disease
Bleackley, M. R., & MacGillivray, R. T. A. (2011) · BioMetals · doi:10.1007/s10534-011-9451-4 · Cited by 231
Lindberg, M. J., Byström, R., Boknäs, N., Andersen, P. M., & Oliveberg, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501957102 · Cited by 232
Deng, Z., Lim, J., Wang, Q., Purtell, K., Wu, S., Palomo, G. M., Tan, H., Manfredi, G., Zhao, Y., Peng, J., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1644076 · Cited by 228
“SOD1 is associated with familial form of ALS and prone to aggregate formation [36].”
BackgroundRoy, J., Minotti, S., Dong, L., Figlewicz, D. A., & Durham, H. D. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09673.1998 · Cited by 231
Self-citationDown’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Wilcock, D. M., & Griffin, W. S. T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-84 · Cited by 230
“Aβ: β-amyloid; AD: Alzheimer's disease; ADMA: Asymmetric dimethylarginine; ALS: Anterolateral sclerosis; APP: Precursor protein of β-amyloid; APP: Precursor protein; BACE2: β-amyloid cleavage enzyme 2; CBS: Cystathionine beta synthase; CNS: Central nervous system; DS: Down’s syndrome; DSCR: Down’s syndrome critical re…”
BackgroundAggresomes and Russell bodies: Symptoms of cellular indigestion?
Kopito, R. R., & Sitia, R. (2000) · EMBO reports · doi:10.1093/embo-reports/kvd052 · Cited by 230
Tamai, K. T., Gralla, E. B., Ellerby, L. M., Valentine, J. S., & Thiele, D. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8013 · Cited by 230
The role of Rho GTPases in disease development
Boettner, B., & Van Aelst, L. (2002) · Gene · doi:10.1016/s0378-1119(02)00426-2 · Cited by 229
Chiu, C.-T., & Chuang, D.-M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.006 · Cited by 229
Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic
Trist, B. G., Hilton, J. B., Hare, D. J., Crouch, P. J., & Double, K. L. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202000451 · Cited by 225
Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS
Petri, S., Körner, S., & Kiaei, M. (2012) · Neurology Research International · doi:10.1155/2012/878030 · Cited by 226
“…2 Department of Neurobiology and Developmental Sciences, Center for Translational Neuroscience, University of Arkansas for Medical Sciences, Little Rock, AR, USA Correspondence should be addressed to Susanne Petri, petri.susanne@mh-hannover.de and Mahmoud Kiaei, mkiaei@uams.edu Received 21…”
BackgroundReactive oxygen species and Alzheimer's disease
Multhaup, G., Ruppert, T., Schlicksupp, A., Hesse, L., Beher, D., Masters, C. L., & Beyreuther, K. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00062-2 · Cited by 227
Cleveland, D. W. (1999) · Neuron · doi:10.1016/s0896-6273(00)81108-3 · Cited by 227
Free radicals: their history and current status in aging and disease.
Knight, J. A. (1998) · PubMed · Cited by 266
A new family of neurotransmitter transporters: the high‐affinity glutamate transporters
Kanai, Y., Smith, C. P., & Hediger, M. A. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.15.7903261 · Cited by 226
“Linkage analysis of an autosomal dominant form of ALS localized the mutant gene to the long arm of chromosome 21. In a recent study Rosen et al. ( 84 ) demonstrated that an autosomal dominant form of ALS is linked to the SOD1 gene, which encodes the cytosolic superoxide dismutase (SOD).”
BackgroundKuo, J. J., Siddique, T., Fu, R., & Heckman, C. J. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.074138 · Cited by 225
“Patients with mutations in the enzyme superoxide dismutase 1 (SOD1) account for approximately 20% of all familial ALS cases (Deng et al. 1993; Rosen et al. 1993; Siddique & Lalani, 2002).”
BackgroundSelf-citationAdvances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies
Vucic, S., Rothstein, J. D., & Kiernan, M. C. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.05.006 · Cited by 225
Furukawa, Y., Fu, R., Deng, H.-X., Siddique, T., & O'Halloran, T. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602048103 · Cited by 224
Self-citationTreatment of a Mouse Model of ALS by In Vivo Base Editing
Lim, C. K. W., Gapinske, M., Brooks, A. K., Woods, W. S., Powell, J. E., Zeballos C., M. A., Winter, J., Perez-Pinera, P., & Gaj, T. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.005 · Cited by 222
“4 To date, more than 100 mutations in the SOD1 gene have been implicated in ALS, and although the role of mutant SOD1 in the pathogenesis of the disorder remains incompletely understood, it is thought that mutant SOD1 expression in both motor neurons 5 and non-neuronal cells 5 – 12 is a driving…”
BackgroundTiwari, A., & Hayward, L. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210419200 · Cited by 224
Azman, K. F., & Zakaria, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126827 · Cited by 221
Ince (1998) · doi:10.1046/j.1365-2990.1998.00108.x · Cited by 224
Mourelatos, Z., Gonatas, N. K., Stieber, A., Gurney, M. E., & Dal Canto, M. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5472 · Cited by 195
Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase
Raha, S., McEachern, G. E., Myint, A. T., & Robinson, B. H. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00338-5 · Cited by 223
Astrocyte-immune cell interactions in physiology and pathology
Han, R. T., Kim, R. D., Molofsky, A. V., & Liddelow, S. A. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.013 · Cited by 223
Oxidative Stress and Motor Neurone Disease
Cookson, M. R., & Shaw, P. J. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00217.x · Cited by 222
Eymard-Pierre, E., Lesca, G., Dollet, S., Santorelli, F. M., di Capua, M., Bertini, E., & Boespflug-Tanguy, O. (2002) · The American Journal of Human Genetics · doi:10.1086/342359 · Cited by 222
“Patients with ALS1 harbor mutations in the superoxide dismutase gene (SOD1 [MIM 147450] (Rosen et al. 1993).”
BackgroundThe Use of Induced Pluripotent Stem Cells in Drug Development
Inoue, H., & Yamanaka, S. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.38 · Cited by 221
Sirtuin deacetylases in neurodegenerative diseases of aging
Herskovits, A. Z., & Guarente, L. (2013) · Cell Research · doi:10.1038/cr.2013.70 · Cited by 219
Landwehrmeyer, G. B., McNeil, S. M., Dure, L. S., Ge, P., Aizawa, H., Huang, Q., Ambrose, C. M., Duyao, M. P., Bird, E. D., Bonilla, E., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410370213 · Cited by 222
Self-citationKetogenic Diet in Neuromuscular and Neurodegenerative Diseases
Paoli, A., Bianco, A., Damiani, E., & Bosco, G. (2014) · BioMed Research International · doi:10.1155/2014/474296 · Cited by 220
Pasinelli, P., Borchelt, D. R., Houseweart, M. K., Cleveland, D. W., & Brown, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15763 · Cited by 221
Self-citationKabuta, T., Suzuki, Y., & Wada, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603337200 · Cited by 219
Sandström, J., Nilsson, P., Karlsson, K., & Marklund, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32289-5 · Cited by 220
Lazaroids improve the survival of grafted rat embryonic dopamine neurons.
Nakao, N., Frodl, E. M., Duan, W. M., Widner, H., & Brundin, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12408 · Cited by 219
Astrocytic dysfunction: Insights on the role in neurodegeneration
Rossi, D., & Volterra, A. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.07.012 · Cited by 219
Michel, T. M., Frangou, S., Thiemeyer, D., Camara, S., Jecel, J., Nara, K., Brunklaus, A., Zoechling, R., & Riederer, P. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.04.013 · Cited by 218
“, 2005) such as amyotrophic lateral sclerosis (Rosen et al., 1993), Alzheimer's dementia (Hashimoto et al.”
BackgroundSchymick, J. C., Scholz, S. W., Fung, H.-C., Britton, A., Arepalli, S., Gibbs, J. R., Lombardo, F., Matarin, M., Kasperaviciute, D., Hernandez, D. G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70037-6 · Cited by 218
BECKMAN, J. S. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21791.x · Cited by 216
Transgenic-Mouse Model of Amyotrophic Lateral Sclerosis
Gurney, M. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412223312516 · Cited by 217
Emde, A., Eitan, C., Liou, L., Libby, R. T., Rivkin, N., Magen, I., Reichenstein, I., Oppenheim, H., Eilam, R., Silvestroni, A., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490493 · Cited by 217
Amyloid peptides and proteins in review
Harrison, R. S., Sharpe, P. C., Singh, Y., & Fairlie, D. P. (2007) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/112_2007_0701 · Cited by 212
Shared Resistance to Aging and ALS in Neuromuscular Junctions of Specific Muscles
Valdez, G., Tapia, J. C., Lichtman, J. W., Fox, M. A., & Sanes, J. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034640 · Cited by 216
“Structural alterations of NMJs have been documented in patients with ALS and in mouse models of ALS that overexpress mutant forms of superoxide dismutase-1 (SOD), known to cause dominant familial ALS in humans [39,40].”
BackgroundKim, S. H., Shanware, N. P., Bowler, M. J., & Tibbetts, R. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154831 · Cited by 214
Song, W., Song, Y., Kincaid, B., Bossy, B., & Bossy-Wetzel, E. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.004 · Cited by 214
“The vast majority of ALS cases are sporadic, whereas only approximately 10% have a familial mode of inheritance (Rosen, 1993).”
BackgroundMitochondrial dysfunction and its role in motor neuron degeneration in ALS
Manfredi, G., & Xu, Z. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.01.002 · Cited by 215
KIAEI, M., KIPIANI, K., CHEN, J., CALINGASAN, N., & BEAL, M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.10.007 · Cited by 214
Metadata
- Authors
- Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Bergh, R., Hung, W.-Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Pericak–Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., & Brown, R. H.
- Affiliations
- Massachusetts General Hospital (US)
- Northwestern University (US)
- Montreal General Hospital (CA)
- Howard Hughes Medical Institute (US)
- North Shore University Hospital (US)
- University of Washington (US)
- Mayo Clinic (US)
- ORCID
- Venue
- Nature
- Published
- 1993-03-01
- Volume
- 362
- Issue
- 6415
- Pages
- 59-62
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2096386031
- Cited by
- 7,062
- References
- 42
- Citations by year
- 2026: 137 · 2025: 154 · 2024: 201 · 2023: 185 · 2022: 254 · 2021: 259 · 2020: 295 · 2019: 205 · 2018: 258 · 2017: 248 · 2016: 242 · 2015: 248 · 2014: 262 · 2013: 264 · 2012: 315
- FWCI
- 174.77
- Type
- journal article
- Language
- en
- Update notices
- correction (1993-07-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, familial ALS, SOD1, Cu/Zn superoxide dismutase, missense mutations, genetic linkage, chromosome 21q, autosomal dominant inheritance, free radical toxicity, candidate genes, motor neuron degeneration
- MeSH terms
- Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Base Sequence, Codon, DNA, Exons, Humans, Isoenzymes, Lod Score, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Oligodeoxyribonucleotides, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Superoxide Dismutase, Genome, Human, Polymerase Chain Reaction, Sequence Homology, Amino Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.